June 2009
Market Update: At a Fork in the Road
June 15, 2009
Last week I took a pretty detailed look at how the market - the S&P 500 in this case - wasn't exactly as bearish as everyone thought it might be, but was instead simply trapped in a range... between 926 and 950. Though I was generally bearish, I had no real 'supporting evidence' for my thesis. I...
Last week I took a pretty detailed look at how the market - the S&P 500 in this case - wasn't exactly as bearish as everyone thought it might be, but was instead simply trapped in a range... between 926 and 950. Though I was generally bearish, I had no real 'supporting evidence' for my thesis. I...
January 2009
Obama & Co. to Turn Pharma Switch 'On'?
January 10, 2009
When we published our recommendation of CEL-SCI (AMEX: CVM) shares on Wednesday morning of this week, we really had no idea some of you would be able to exit at our target price of 40 cents by Thursday afternoon. I've triple-checked it since then though, and it's true - there were a few transactions...
When we published our recommendation of CEL-SCI (AMEX: CVM) shares on Wednesday morning of this week, we really had no idea some of you would be able to exit at our target price of 40 cents by Thursday afternoon. I've triple-checked it since then though, and it's true - there were a few transactions...
Big Pharma's Paradigm Shift = Biotech Investment Opportunity
January 07, 2009
With both the market and the economy apparently poised to begin improving, I know we're all interested in trading ideas that will start the portfolio-recovery process. What's interesting about today's idea, though, is how the bear market may have actually obscured the opportunity's development. Today...
With both the market and the economy apparently poised to begin improving, I know we're all interested in trading ideas that will start the portfolio-recovery process. What's interesting about today's idea, though, is how the bear market may have actually obscured the opportunity's development. Today...
